Skip to main content
logo
Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China flag China · Delayed Price · Currency is CNY
18.64
+0.47 (2.59%)
Jan 23, 2026, 3:00 PM CST

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
New HIV Drug (Enomide Tablets)
133.54M
Log In
Log In
Log In
Log In
Upgrade
New HIV Drug (Enomide Tablets) Growth
173.41%
Log In
Log In
Log In
Log In
Upgrade
Medicines (Urokinase Injection)
80.04M
Log In
Log In
Log In
Log In
Upgrade
Senna Granules
55.36M
Log In
Log In
Log In
Log In
Upgrade
Senna Granules Growth
-13.99%
Log In
Log In
Log In
Log In
Upgrade
Ulinastatin Crude
50.47M
Log In
Log In
Log In
Log In
Upgrade
Ulinastatin Crude Growth
-36.56%
Log In
Log In
Log In
Log In
Upgrade
Crude Urokinase
45.15M
Log In
Log In
Log In
Log In
Upgrade
Crude Urokinase Growth
-74.49%
Log In
Log In
Log In
Log In
Upgrade
Other Human Protein Crude
17.46M
Log In
Log In
Log In
Log In
Upgrade
Other Human Protein Crude Growth
443.30%
Log In
Log In
Log In
Log In
Upgrade
New HIV Drug (AnovirinTablets)
16.36M
Log In
Log In
Log In
Log In
Upgrade
New HIV Drug (AnovirinTablets) Growth
-33.87%
Log In
Log In
Log In
Log In
Upgrade
Other Drugs
11.55M
Log In
Log In
Log In
Log In
Upgrade
HIV Diagnostic Reagents
3.35M
Log In
Log In
Log In
Log In
Upgrade
HIV Diagnostic Reagents Growth
-53.72%
Log In
Log In
Log In
Log In
Upgrade
Other
4.53M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
11433.48%
Log In
Log In
Log In
Log In
Upgrade
Bacillus Cereus Tablets
-
Log In
Log In
Log In
Log In
Upgrade
Bacillus Cereus Tablets Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Business
-
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-
Log In
Log In
Log In
Log In
Upgrade
HIV Diagnostic Equipment
-
Log In
Log In
Log In
Log In
Upgrade
HIV Diagnostic Equipment Growth
-
Log In
Log In
Log In
Log In
Upgrade
Ureklin Crude
-
Log In
Log In
Log In
Log In
Upgrade
Ureklin Crude Growth
-
Log In
Log In
Log In
Log In
Upgrade
Crude Ulinastatin (Exported to India)
-
Log In
Log In
Log In
Log In
Upgrade
Crude Ulinastatin (Exported to India) Growth
-
Log In
Log In
Log In
Log In
Upgrade
HIV Drug Points
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
China
417.80M
Log In
Log In
Log In
Log In
Upgrade
China Growth
1.57%
Log In
Log In
Log In
Log In
Upgrade